Repurposing rheumatology drugs for COVID-19: TNF inhibitors (with Philip Robinson)
Miscellaneous
Philip Robinson discusses why TNF inhibitors may be a favorable treatment option for COVID-19 and outlines the trials that are currently underway.
Repurposing rheumatology drugs for COVID-19: TNF inhibitors (with Philip Robinson)
Share: